{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:57:45Z","timestamp":1779908265406,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1038\/nm0396-334","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:40:26Z","timestamp":1092879626000},"page":"334-337","source":"Crossref","is-referenced-by-count":136,"title":["Auxotrophic vaccines for tuberculosis"],"prefix":"10.1038","volume":"2","author":[{"given":"Indira","family":"Guleria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganjam","family":"Kalpana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0396334_CR1","first-page":"53","volume-title":"Expenditures and Intervention Packages","author":"CJL Murray","year":"1994","unstructured":"Murray, C.J.L. & Lopez, A.D. Global Comparative Assessments in the Health Sector: Disease Burden, Expenditures and Intervention Packages (eds. Murray, C.J.L. & Lopez, A.D.) 53 (World Health Organization, Geneva, 1994)."},{"key":"BFnm0396334_CR2","first-page":"503","volume-title":"Tuberculosis, Pathogenesis, Protection and Control","author":"S Lucas","year":"1994","unstructured":"Lucas, S. & Nelson, A.M. Pathogenesis of tuberculosis in human immunodeficiency virus infected people. in Tuberculosis, Pathogenesis, Protection and Control (ed. Bloom, B.R.) 503\u2013513 (American Society for Microbiology Press, Washington, DC, 1994)."},{"key":"BFnm0396334_CR3","unstructured":"Program for Immunization. Program Report (World Health Organization, Geneva, 1992)."},{"key":"BFnm0396334_CR4","first-page":"1","volume":"24","author":"K Styblo","year":"1991","unstructured":"Styblo, K. Epidemiology of tuberculosis. Selected Papers R. Netherlands Tuberc. Assoc. 24, 1\u2013136 (1991).","journal-title":"Selected Papers R. Netherlands Tuberc. Assoc."},{"key":"BFnm0396334_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJM198903023200901","volume":"320","author":"PA Selwyn","year":"1989","unstructured":"Selwyn, P.A. et al. A prospective study of the risk of tuberculosis among intravenous drug abusers with human immunodeficiency virus infection. N. Engl. J. Med. 320, 545\u2013550 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0396334_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","volume":"22","author":"LC Rodrigues","year":"1993","unstructured":"Rodrigues, L.C., Diwan, V.K. & Wheeler, J.G. Protective efficacy of BCG against tuberculousmeningitisandmiliary tuberculosis: Meta-analysis. Int. J. Epidemiol. 22, 1154\u20131158 (1993).","journal-title":"Int. J. Epidemiol."},{"key":"BFnm0396334_CR7","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","volume":"11","author":"PEM Fine","year":"1989","unstructured":"Fine, P.E.M. The BCG story: Lessons from the past and implications for the future. Rev. Infect. Dis. 11, S353\u2013S359 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm0396334_CR8","first-page":"255","volume":"54","author":"HG tenDam","year":"1976","unstructured":"tenDam, H.G., Toman, K.I., Hitze, K.L., & Guld, J., Present knowledge of immunization against tuberculosis. Bull World Health Organ. 54, 255\u2013269 (1976).","journal-title":"Bull World Health Organ."},{"key":"BFnm0396334_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","volume":"22","author":"PD Hart","year":"1977","unstructured":"Hart, P.D. & Sutherland, I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br. Med. J. 22, 293\u2013295 (1977).","journal-title":"Br. Med. J."},{"key":"BFnm0396334_CR10","unstructured":"Trial of BCG vaccines in South India for tuberculosis prevention. Indian J. Med. Res. 72, 1\u201374 (1980)."},{"key":"BFnm0396334_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/9781555818357.ch31","volume-title":"The BCG Experience: Implications for future vaccines against tuberculosis, in Tuberculosis, Pathogenesis, Protection and Control","author":"BR Bloom","year":"1994","unstructured":"Bloom, B.R. & Fine, P.E.M. The BCG Experience: Implications for future vaccines against tuberculosis, in Tuberculosis, Pathogenesis, Protection and Control (ed. Bloom, B.R.) 531\u2013557 (American Society for Microbiology Press, Washington, DC, 1994)."},{"key":"BFnm0396334_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/ACPJC-1994-121-1-022","volume":"121","author":"GA Colditz","year":"1994","unstructured":"Colditz, G.A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of published literature [see comments] (1994). Comments in: ACP J. Club 121 (Jul-Aug), Suppl. 1, 22 (1994); Comment in: JAMA 272, 765 (1994); Discussion 766.","journal-title":"ACP J. Club"},{"key":"BFnm0396334_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(87)92451-2","volume":"ii","author":"CF vonReyn","year":"1987","unstructured":"vonReyn, C.F. et al. Human immunodeficiency virus infection and routine childhood immunization. Lancet ii, 669\u2013672 (1987).","journal-title":"Lancet"},{"key":"BFnm0396334_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00006454-199203000-00010","volume":"11","author":"MM Braun","year":"1992","unstructured":"Braun, M.M. & Cauthen, G. Relationship of the human deficiency virus epidemic to paediatric tuberculosis and bacillus Calmette-Guerin immunization. Pediatr. Infect. Dis. J. 11, 220\u2013227 (1992).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnm0396334_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00002030-199302000-00001","volume":"7","author":"AC Weltman","year":"1993","unstructured":"Weltman, A.C. & Rose, D.N. The safety of bacille Calmette-Guerin vaccination in HIV infection and AIDS. AIDS 7, 149\u2013157 (1993).","journal-title":"AIDS"},{"key":"BFnm0396334_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","volume":"131","author":"R Germanier","year":"1975","unstructured":"Germanier, R. & Furer, E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: A candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131, 553\u2013558 (1975).","journal-title":"J. Infect. Dis."},{"key":"BFnm0396334_CR17","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/IAI.55.12.3035-3043.1987","volume":"55","author":"R Curtiss","year":"1987","unstructured":"Curtiss, R. III, & Kelly, S.M., Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55, 3035\u20133043 (1987).","journal-title":"Infect. Immun."},{"key":"BFnm0396334_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/291238a0","volume":"291","author":"S Hoiseth","year":"1981","unstructured":"Hoiseth, S. & Stocker, B.A.D. Aromatic dependent Salmonella typhimurium are non-virulent and are effective as live vaccines. Nature 291, 238\u2013239 (1981).","journal-title":"Nature"},{"issue":"6","key":"BFnm0396334_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/infdis\/158.6.1329","volume":"158","author":"G. Dougan","year":"1988","unstructured":"Dougan, G. et al. Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes. J. Infect. Dis. 158, 1329 (1988).","journal-title":"Journal of Infectious Diseases"},{"key":"BFnm0396334_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/BF00339734","volume":"215","author":"IA Miller","year":"1989","unstructured":"Miller, I.A. et al. Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: Use in identifying a role for aroD in attenuating virulent Salmonella strains. Mol. Gen. Genet. 215, 312\u2013316 (1989).","journal-title":"Mol. Gen. Genet."},{"key":"BFnm0396334_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/infdis\/145.3.292","volume":"145","author":"MH Wahdan","year":"1982","unstructured":"Wahdan, M.H., Serie, C., Cerisier, Y., Sallam, S. & Germanier, R. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: Three-year results. J. Infect. Dis. 145, 292\u2013295 (1982).","journal-title":"J. Infect. Dis."},{"key":"BFnm0396334_CR22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/IAI.63.3.1004-1012.1995","volume":"63","author":"RA McAdam","year":"1995","unstructured":"McAdam, R.A. et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis-BCG generated by transposon mutagenesis. Infect. Immun. 63, 1004\u20131012 (1995).","journal-title":"Infect. Immun."},{"key":"BFnm0396334_CR23","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1073\/pnas.88.12.5433","volume":"88","author":"K Ganjam","year":"1991","unstructured":"Ganjam, K., Bloom, B.R. & Jacobs, W.R., Jr. Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc. Natl. Acad. Sci. USA 88, 5433\u20135443 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0396334_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.177.6.1723","volume":"177","author":"RJ North","year":"1993","unstructured":"North, R.J. & Izzo, A.A. Mycobacterial virulence: Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 177, 1723\u20131733 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0396334_CR25","doi-asserted-by":"crossref","unstructured":"Orme, I.M. and Collins, F.M. Mouse model of tuberculosis, in Tuberculosis, Pathogenesis, Protection and Control (ed. Bloom, B.R.) 113\u2013134 (American Society for Microbiology Press, Washington, DC, 1994).","DOI":"10.1128\/9781555818357.ch8"},{"key":"BFnm0396334_CR26","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1084\/jem.178.6.2243","volume":"178","author":"AM Cooper","year":"1993","unstructured":"Cooper, A.M. et al. Disseminated tuberculosis in IFN-\u03b3 gene-disrupted mice. J. Exp. Med. 178, 2242\u20132248 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0396334_CR27","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn, J.L. et al. An essential role for IFN-\u03b3 in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249\u20132254 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0396334_CR28","doi-asserted-by":"publisher","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","volume":"89","author":"JL Flynn","year":"1992","unstructured":"Flynn, J.L., Goldstein, M.M., Triebold, K.J., Koller, B. & Bloom, B.R. Major histocompatibility class I-restricted T-cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89, 12013\u201312017 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0396334_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","volume":"2","author":"JL Flynn","year":"1995","unstructured":"Flynn, J.L. et al. Tumor necrosis factor a is required in the protective immune response against M. tuberculosis in mice. Immunity 2, 561\u2013572, 1995.","journal-title":"Immunity"},{"key":"BFnm0396334_CR30","first-page":"423","volume":"84","author":"AM Cooper","year":"1995","unstructured":"Cooper, A.M. et al. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84, 423\u2013432 (1995).","journal-title":"Immunology"},{"key":"BFnm0396334_CR31","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.4049\/jimmunol.155.5.2515","volume":"155","author":"JL Flynn","year":"1995","unstructured":"Flynn, J.L., Goldstein, M.M., Triebold, K.J., Wolf, S. & Bloom, B.R. IL-12 increases resistance of BALB\/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155, 2515\u20132524 (1995).","journal-title":"J. Immunol."},{"key":"BFnm0396334_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.178.1.197","volume":"178","author":"CK Stover","year":"1993","unstructured":"Stover, C.K. et al. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine. J. Exp. Med. 178, 197\u2013209 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0396334_CR33","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","volume":"90","author":"ND Connell","year":"1993","unstructured":"Connell, N.D., Medina-Acosta, E., McMaster, W.R., Bloom, B.R. & Russell, D.G. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90, 11473\u201311477 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0396334_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","volume":"172","author":"GJ Fennelly","year":"1995","unstructured":"Fennelly, G.J., Flynn, J.L., terMeulen, V., Liebert, U., & Bloom, B.R., Recombinant bacille Calmette-Guerin (BCG) (rBCG) priming against measles. J. Infect. Dis. 172, 698\u2013705 (1995).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0396-334","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0396-334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0396-334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:11:07Z","timestamp":1684447867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0396-334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BFnm0396334"],"URL":"https:\/\/doi.org\/10.1038\/nm0396-334","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}